miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor

By Guo Jinling   Xia Bairong   Meng Fanling   Lou Ge  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1557-1564

Springer Publishing Company

Access to resources Recommend Favorite

The insulin-like growth factor-1 and expression of its binding protein3 in chronic hepatitis C and hepatocellular carcinoma

By                

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1337-1345

Spandidos Publications

Access to resources Recommend Favorite

Elevated Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-2 in Malignant Pleural Effusion

By Olchovsky David   Shimon Ilan   Goldberg Iris   Shulimzon Tiberiu   Lubetsky Aharon   Yellin Alon   Pariente Clara   Karasik Avraham   Kanety Hannah  

Acta Oncologica, Vol. 41, Iss. 2, 2002-04 ,pp. : 182-187

Informa Healthcare

Access to resources Recommend Favorite

Variation in Plasma Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3: Personal and Lifestyle Factors (United States)

By Morimoto Libby M.  

Cancer Causes and Control, Vol. 16, Iss. 8, 2005-10 ,pp. : 917-927

Springer Publishing Company

Access to resources Recommend Favorite

Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas

By Wu Pei-Fang   Huang Wen-Chang   Yang James   Lu Yen-Shen   Shih Jin-Yuan   Wu Shang-Gin   Lin Ching-Hung   Cheng Ann-Lii  

Journal of Neuro-Oncology, Vol. 115, Iss. 1, 2013-10 ,pp. : 61-70

Springer Publishing Company

Access to resources Recommend Favorite